Zhao, Y., Liu, X., Wang, L., Pan, X., Pan, F., & Ke, Q. (2024). MiR-302 targets PAK5 and prevents the transition from chronic hepatitis B to liver cirrhosis. Journal of the Pakistan Medical Association, 74(12), 2114–2121. https://doi.org/10.47391/JPMA.11128